| Dr Ari Max Perkins, MD | |
|
24 Stevens St, Norwalk, CT 06850-3852 | |
| (203) 852-2016 | |
| Not Available |
| Full Name | Dr Ari Max Perkins |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 24 Stevens St, Norwalk, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679596381 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 039474 (Connecticut) | Primary |
| Entity Name | Danbury Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548293343 PECOS PAC ID: 1557273935 Enrollment ID: O20031104000476 |
News Archive
Pearl Therapeutics Inc., a company developing clinically differentiated double and triple combination therapies for the treatment of highly prevalent chronic respiratory diseases, presented results from four studies that provide support for further development of PT003, the company's fixed dose combination of glycopyrrolate and formoterol delivered via a pressurized hydrofluoroalkane metered dose inhaler (HFA-MDI).
Scientists may have found a way to pull down the protective wall that surrounds tumors, potentially re-exposing them to the killing power of the immune system and immunotherapy treatments, according to a study part funded by Cancer Research UK and published in EBioMedicine today (Monday).
Black baby girls born weighing 2.2 pounds or less are more than twice as likely to survive as white baby boys born at the same weight, when many preemies are still too tiny to make it on their own, University of Florida researchers have found.
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, today announced that it has been granted European Medicines Agency (EMA) approval to market Colobreathe dry powder colistimethate sodium for inhalation for treating cystic fibrosis patients aged 6 years and older with chronic lung infection caused by P. aeruginosa.
Men who take a daily multivitamin supplement have a modest reduction in their risk for developing cancer, suggest results from the Physicians' Health Study II.
› Verified 2 days ago
| Entity Name | Nuvance Health Medical Practice Ct Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407898117 PECOS PAC ID: 4789597691 Enrollment ID: O20031205000130 |
News Archive
Pearl Therapeutics Inc., a company developing clinically differentiated double and triple combination therapies for the treatment of highly prevalent chronic respiratory diseases, presented results from four studies that provide support for further development of PT003, the company's fixed dose combination of glycopyrrolate and formoterol delivered via a pressurized hydrofluoroalkane metered dose inhaler (HFA-MDI).
Scientists may have found a way to pull down the protective wall that surrounds tumors, potentially re-exposing them to the killing power of the immune system and immunotherapy treatments, according to a study part funded by Cancer Research UK and published in EBioMedicine today (Monday).
Black baby girls born weighing 2.2 pounds or less are more than twice as likely to survive as white baby boys born at the same weight, when many preemies are still too tiny to make it on their own, University of Florida researchers have found.
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, today announced that it has been granted European Medicines Agency (EMA) approval to market Colobreathe dry powder colistimethate sodium for inhalation for treating cystic fibrosis patients aged 6 years and older with chronic lung infection caused by P. aeruginosa.
Men who take a daily multivitamin supplement have a modest reduction in their risk for developing cancer, suggest results from the Physicians' Health Study II.
› Verified 2 days ago
| Entity Name | Norwalk Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427041581 PECOS PAC ID: 3375436660 Enrollment ID: O20040202000988 |
News Archive
Pearl Therapeutics Inc., a company developing clinically differentiated double and triple combination therapies for the treatment of highly prevalent chronic respiratory diseases, presented results from four studies that provide support for further development of PT003, the company's fixed dose combination of glycopyrrolate and formoterol delivered via a pressurized hydrofluoroalkane metered dose inhaler (HFA-MDI).
Scientists may have found a way to pull down the protective wall that surrounds tumors, potentially re-exposing them to the killing power of the immune system and immunotherapy treatments, according to a study part funded by Cancer Research UK and published in EBioMedicine today (Monday).
Black baby girls born weighing 2.2 pounds or less are more than twice as likely to survive as white baby boys born at the same weight, when many preemies are still too tiny to make it on their own, University of Florida researchers have found.
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, today announced that it has been granted European Medicines Agency (EMA) approval to market Colobreathe dry powder colistimethate sodium for inhalation for treating cystic fibrosis patients aged 6 years and older with chronic lung infection caused by P. aeruginosa.
Men who take a daily multivitamin supplement have a modest reduction in their risk for developing cancer, suggest results from the Physicians' Health Study II.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ari Max Perkins, MD 24 Stevens St, Norwalk, CT 06850-3852 Ph: (203) 852-2016 | Dr Ari Max Perkins, MD 24 Stevens St, Norwalk, CT 06850-3852 Ph: (203) 852-2016 |
News Archive
Pearl Therapeutics Inc., a company developing clinically differentiated double and triple combination therapies for the treatment of highly prevalent chronic respiratory diseases, presented results from four studies that provide support for further development of PT003, the company's fixed dose combination of glycopyrrolate and formoterol delivered via a pressurized hydrofluoroalkane metered dose inhaler (HFA-MDI).
Scientists may have found a way to pull down the protective wall that surrounds tumors, potentially re-exposing them to the killing power of the immune system and immunotherapy treatments, according to a study part funded by Cancer Research UK and published in EBioMedicine today (Monday).
Black baby girls born weighing 2.2 pounds or less are more than twice as likely to survive as white baby boys born at the same weight, when many preemies are still too tiny to make it on their own, University of Florida researchers have found.
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, today announced that it has been granted European Medicines Agency (EMA) approval to market Colobreathe dry powder colistimethate sodium for inhalation for treating cystic fibrosis patients aged 6 years and older with chronic lung infection caused by P. aeruginosa.
Men who take a daily multivitamin supplement have a modest reduction in their risk for developing cancer, suggest results from the Physicians' Health Study II.
› Verified 2 days ago
Dr. Timothy Daniel Shub, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 34 Maple St, Norwalk, CT 06850 Phone: 203-852-2000 | |
Dr. Arthur Strichman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 34 Maple St, Norwalk, CT 06850 Phone: 203-852-2281 | |
Dr. Bharat Patel, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 235 Main Ave, Norwalk, CT 06851 Phone: 203-847-2600 | |
Steven Gary Berger, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 346 Main Ave, Norwalk, CT 06851 Phone: 203-846-0005 Fax: 203-846-0012 | |
Dr. Jean Marie Hammel, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 24 Stevens Street, Norwalk Hospital Emergency Department, Norwalk, CT 06856 Phone: 203-852-2281 | |
Dr. Elizabeth Dt Kassapidis, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 Stevens St, Norwalk, CT 06850 Phone: 203-852-2281 | |
Dr. Richard J Teitell, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 24 Stevens St, Norwalk, CT 06850 Phone: 203-852-2160 |